Dihydronarwedine-d3 is the Isotope labelled analogue of Dihydroarwedine (D453580), a metabolite of Galanthamine (G188500). Galanthamine is a known selective acetylcholinesterase inhibitor and therapeutic agent for the treatment and prevention of Alzheimer’s disease and disorders resulting from reduced neuronal metabolism.